 |
|
 |
 |

Home > Company Index > Drugs > Drug Manufacturers - Major > Tularik Inc.
 |
Tularik Inc. |
 |
 |
 |
NEWS FROM THE WIRES |
 |
Tularik files $250 mln shelf offering Aug 13 2001 12:16 PM PDT
HK stocks end higher, led by key China tech plays Jul 12 2001 02:18 AM PDT
China IPO guidelines sparks hope for HK red chips Jul 12 2001 02:17 AM PDT
Hong Kong Hot Stocks-Beijing N.Star loses shine Jul 12 2001 02:06 AM PDT
Protherics sells drug design to Tularik Jul 12 2001 02:05 AM PDT
> More WIRE STORIES about this company
NEWS FROM THE STANDARD |
 |
IPO Weekly: Checking in With the Hardy Few IPO Funds
Mar 30 2001 03:46 PM PST
PROFILE |
 |
Tularik is trying to get mouthy with disease, developing oral drugs that use gene regulation to treat various conditions. The company (named for the Alaskan river where its angling founders thought up the enterprise) has several drugs in its pipeline, including a cancer-fighting candidate, licensed from Eli Lilly. The company is also conducting human tests for two other anti-cancer drugs and one anti-cytomegalovirus drug. Tularik has research alliances with Knoll AG (obesity), Roche Bioscience (inflammation), and Japan Tobacco (lipid disorders,obesity/diabetes, metabolic diseases). Pharma Vision 2000, a Swiss firm, owns about 21% of Tularik.
COMPETITION |
 |
Elan Corporation, plc (ELN)
Emisphere Technologies, Inc. (EMIS)
Provalis plc (PVLS)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
2000 Sales (mil.): 25.50
1-Yr. Sales Growth: 7.1%
Employees: 279
Revenue per employee: $91,397.85
KEY PEOPLE |
 |
David V. Goeddel
CEO
Corinne H. Lyle
CFO
CONTACT INFO |
 |
2 Corporate Dr.
S. San Francisco, CA 94080
US
Phone: 650-825-7000
Fax: 650-825-7303
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |